跳至主要内容
临床试验/EUCTR2008-004534-24-GB
EUCTR2008-004534-24-GB进行中(未招募)1 期

Can high-dose vitamin D supplementation reduce blood pressure and markers of cardiovascular risk in older people with isolated systolic hypertension? - Vitamin D in ISH

niversity of Dundee0 个研究点目标入组 180 人开始时间: 2008年10月16日最近更新:
适应症
相关药物

试验速览

阶段
1 期
状态
进行中(未招募)
发起方
入组人数
180

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional clinical trial of medicinal product

入排标准

性别
All

入选标准

  • Age > or = 70 yrs
  • Office systolic BP > or = 140 mmHg
  • Serum 25 Hydroxy vitamin D <75nmol/L
  • Are the trial subjects under 18? no
  • Number of subjects for this age range:
  • F.1.2 Adults (18-64 years) no
  • F.1.2.1 Number of subjects for this age range
  • F.1.3 Elderly (>=65 years) yes
  • F.1.3.1 Number of subjects for this age range

排除标准

  • Hypertension known to be due to a correctable underlying medical or surgical cause
  • Diastolic blood pressure >90mmHg
  • Systolic blood pressure >180mmHg
  • Estimated glomerular filtration rate <40mls/min (by 4 variable MDRD equation)
  • Liver function tests (ALT, Bilirubin, Alkaline phosphatase) >3x normal
  • Corrected calcium >2.60 mmol/L or <2.15 mmol/L
  • Known metastatic malignancy or sarcoidosis
  • Clinical diagnosis of osteomalacia
  • History of renal calculi
  • Diagnosis of heart failure with left ventricular systolic dysfunction.
  • Atrial fibrillation
  • Already taking vitamin D supplements. Consumption of fish oils will not be a contraindication to enrolment
  • Unable to give written informed consent

研究者

发起方
niversity of Dundee

相似试验